Options: Show MedDRA Preferred Terms
Side effect | Data for drug | Placebo | Labels | |
---|---|---|---|---|
1 | 2 | |||
Vomiting | 22% | x | x | |
Nausea | 20% | x | x | |
Diarrhoea | 19% | x | x | |
Dyspepsia | 16% | x | x | |
Flatulence | 8% | x | x | |
Abdominal pain | postmarketing, 9% | x | x | |
Constipation | postmarketing, 8% | x | x | |
Rash | postmarketing | x | x | |
Faecalith | postmarketing | x | ||
Intestinal obstruction | postmarketing | x | x | |
Intestinal perforation | postmarketing | x | x | |
Pruritus | postmarketing | x | x | |
Ileus | postmarketing | x | x | |
Gastrointestinal disorder | x | |||
Peritonitis | x | |||
Abdominal pain upper | x | |||
Subileus | x |
Information about indications was extracted from the indications and usage sections of the labels.
standard – alternative
100% | ||
75% | ||
50% | ||
10% | ||
frequent (1% to 100%) | ||
infrequent (0.1% to 1%) | ||
rare (<0.1%) | ||
postmarketing | ||
0% | ||
no frequency information | ||
not found on label |